Gietema, J A

Predictors of adherence to exercise interventions during and after cancer treatment: A systematic review

Ormel, H. L., van der Schoot, G. G. F., Sluiter, W. J., Jalving, M., Gietema, J. A., & Walenkamp, A. M. E. (2018) · Psycho-Oncology

Cancer survivorship and carePhysical Activity and Health

Cited by 261

A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours

Eskens, F. A. L. M., Mom, C. H., Planting, A. S. T., Gietema, J. A., Amelsberg, A., Huisman, H., van Doorn, L., Burger, H., Stopfer, P., Verweij, J., et al. (2008) · British Journal of Cancer

HER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations

Cited by 234

Risk of Solid Cancer after Treatment of Testicular Germ Cell Cancer in the Platinum Era

Groot, H. J., Lubberts, S., de Wit, R., Witjes, J. A., Kerst, J. M., de Jong, I. J., Groenewegen, G., van den Eertwegh, A. J. M., Poortmans, P. M., Klümpen, H.-J., et al. (2018) · Journal of Clinical Oncology

Multiple and Secondary Primary CancersTesticular diseases and treatments

Cited by 88

In vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo

Yao, K., Gietema, J. A., Shida, S., Selvakumaran, M., Fonrose, X., Haas, N. B., Testa, J., & O'Dwyer, P. J. (2005) · British Journal of Cancer

Cancer, Hypoxia, and MetabolismAngiogenesis and VEGF in Cancer

Cited by 82

Early ageing after cytotoxic treatment for testicular cancer and cellular senescence: Time to act

Lubberts, S., Meijer, C., Demaria, M., & Gietema, J. A. (2020) · Critical Reviews in Oncology/Hematology

Telomeres, Telomerase, and SenescenceChildhood Cancer Survivors' Quality of Life

Cited by 19